Trials / Conditions / HR-positive Breast Cancer
HR-positive Breast Cancer
4 registered clinical trials studyying HR-positive Breast Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Phase III Study to Evaluate the Safety, Efficacy, and Impact on Quality of Life of Capivasertib Alongside Stan NCT07281833 | West German Study Group | Phase 3 |
| Recruiting | Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advan NCT06805812 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | — |
| Withdrawn | Vitamin B12 for Aromatase Inhibitors Associated Musculoskeletal Symptoms in Breast Cancer NCT04205786 | Case Comprehensive Cancer Center | N/A |
| Active Not Recruiting | Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC NCT04448886 | Ana C Garrido-Castro, MD | Phase 2 |